A study published in the Proceedings of the National Academy of Sciences has uncovered new clues to why some therapeutic proteins are so difficult to manufacture. The work—led by Nathan Lewis, PhD, ...
Chinese hamster ovary (CHO) cells were the protein production platform used in 89% of the biologics drugs approved between 2018 and 2022, and their use does not appear to be slowing. Manufacturers are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results